We are live on ! Find out more
SRTS icon

Sensus Healthcare

21 hedge funds and large institutions have $5.02M invested in Sensus Healthcare in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

0.44% less ownership

Funds ownership: 8.35% → 7.9% (-0.44%)

9% less funds holding

Funds holding: 23 → 21 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

73% less capital inflows, than outflows

Capital inflows: $100K | Capital outflows: $377K

Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
6
Closed
3
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

SRTS Hedge Fund Activity: Q2 2021 in Review

21 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q2 2021, worth a combined $5.02M — down 4.8% from $5.27M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SRTS and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was Geode Capital Management, adding an estimated $39.8K. The largest seller was Morgan Stanley, cutting an estimated $130K.

  • 21 institutional investors held Sensus Healthcare (SRTS) as of Q2 2021, down from 23 in Q1 2021.
  • Funds reported $5.02M of Sensus Healthcare stock for Q2 2021, down 4.8% quarter-over-quarter.
  • 1 fund opened new Sensus Healthcare positions in Q2 2021 and 3 closed out, a net change of -2 holders.
  • The largest Sensus Healthcare buyer in Q2 2021 was Geode Capital Management, an estimated $39.8K added.
  • The largest Sensus Healthcare seller in Q2 2021 was Morgan Stanley, an estimated $130K sold.

Based on aggregated 13F filings for Q2 2021.